Common prostate cancer treatment which shuts off the body's supply of testosterone DOUBLES the risk of dementia



Hormone treatments taken by thousands of men with prostate cancer could double their risk of developing dementia, research suggests.
Roughly 18,000 men in Britain start taking hormone pills or injections every year - nearly 40 per cent of the 47,000 men diagnosed with prostate cancer.
The treatments work by lowering levels of testosterone, a hormone which is normally harmless but in prostate cancer patients can drive the growth of tumours.
The therapy is a standard treatment for men whose cancers have started to spread and cannot be eliminated by surgery or radiotherapy alone.
But a study... read more

 
13 October 2016 in Health, Views: 43
Source: Daily Mail
Share:
  •  





    News Widget for Webmasters



    Bring Eugene's son back home immediately

    Realtime News

     

    «
    »
    Mo Tu We Th Fr Sa Su
          1 2 3 4
    5 6 7 8 9 10 11
    12 13 14 15 16 17 18
    19 20 21 22 23 24 25
    26 27 28 29 30 31